Bacterial Gastroenteritis

While bacterial gastroenteritis is typically a self-limiting illness, complications may arise, particularly in vulnerable populations. Dehydration is a common concern due to fluid loss through diarrhea and vomiting. In severe cases, bacterial invasion of the intestinal lining can lead to bloody diarrhea, a hallmark of certain infections such as Shigella or enterohemorrhagic E. coli. Moreover, post-infectious complications like reactive arthritis or hemolytic-uremic syndrome (HUS) may occur, especially following infections with certain strains of E. coli. The emergence of antibiotic-resistant strains poses challenges in the management of bacterial gastroenteritis. Overuse and misuse of antibiotics contribute to the development of resistant strains, impacting treatment efficacy. Multidrug-resistant Salmonella and Shigella strains, for instance, have raised concerns globally. Enhanced surveillance and judicious use of antibiotics are crucial to mitigate the spread of resistant bacteria and optimize treatment outcomes. In addition to traditional bacterial pathogens, emerging issues include the recognition of non-typhoidal Salmonella as a significant cause of invasive bloodstream infections, highlighting the evolving nature of bacterial gastroenteritis. Ongoing research aims to better understand the epidemiology, pathogenesis, and antibiotic resistance patterns of bacterial gastroenteritis, contributing to improved diagnostics, treatment strategies, and public health interventions.